Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6618 | 1463 | 30.5 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
529 | 3 | CHILDHOOD CANCER//JUVENILE IDIOPATHIC ARTHRITIS//LATE EFFECTS | 20001 |
2953 | 2 | PREGNANCY//HYPERREACTIO LUTEINALIS//PREGNANCY ASSOCIATED BREAST CANCER | 2672 |
6618 | 1 | PREGNANCY ASSOCIATED BREAST CANCER//PREGNANCY//FETAL DOSE | 1463 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PREGNANCY ASSOCIATED BREAST CANCER | authKW | 243021 | 1% | 61% | 19 |
2 | PREGNANCY | authKW | 225334 | 45% | 2% | 657 |
3 | FETAL DOSE | authKW | 184218 | 1% | 55% | 16 |
4 | LACTATING ADENOMA | authKW | 104350 | 0% | 100% | 5 |
5 | PERIPHERAL DOSE | authKW | 90532 | 1% | 27% | 16 |
6 | PLACENTAL METASTASES | authKW | 83480 | 0% | 100% | 4 |
7 | GONADAL DOSE | authKW | 70290 | 1% | 42% | 8 |
8 | LEUVEN CANC LKI | address | 68297 | 0% | 55% | 6 |
9 | CHEMOTHERAPY IN PREGNANCY | authKW | 66783 | 0% | 80% | 4 |
10 | CERVICAL CANCER IN PREGNANCY | authKW | 62610 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Obstetrics & Gynecology | 25403 | 40% | 0% | 583 |
2 | Oncology | 7520 | 38% | 0% | 551 |
3 | Hematology | 739 | 8% | 0% | 111 |
4 | Radiology, Nuclear Medicine & Medical Imaging | 435 | 8% | 0% | 115 |
5 | Medicine, General & Internal | 395 | 9% | 0% | 134 |
6 | Reproductive Biology | 193 | 3% | 0% | 38 |
7 | Pathology | 109 | 3% | 0% | 46 |
8 | Pediatrics | 65 | 3% | 0% | 49 |
9 | Surgery | 46 | 5% | 0% | 79 |
10 | Primary Health Care | 30 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUVEN CANC LKI | 68297 | 0% | 55% | 6 |
2 | FERTIL PROCREAT UNIT ONCOL | 62610 | 0% | 100% | 3 |
3 | PROMOT SUPPORTING PROGRAM | 41740 | 0% | 100% | 2 |
4 | SAFETY QUAL SURG CARE PROJECT | 41740 | 0% | 100% | 2 |
5 | UP 4053 | 41740 | 0% | 100% | 2 |
6 | UZ GASTHUISBERGLEUVEN CANC LKI | 41740 | 0% | 100% | 2 |
7 | ONCOL HOSP MED | 27825 | 0% | 67% | 2 |
8 | AFDELING D | 20870 | 0% | 100% | 1 |
9 | AMBULATORY ONCOL HLTH CARE BERLIN SEESTR | 20870 | 0% | 100% | 1 |
10 | AREA ENFERMEDADES DIGEST | 20870 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 7452 | 3% | 1% | 40 |
2 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 7268 | 2% | 1% | 32 |
3 | OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 6890 | 2% | 2% | 22 |
4 | BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY | 5053 | 1% | 2% | 15 |
5 | GYNECOLOGIC ONCOLOGY | 4897 | 4% | 0% | 52 |
6 | OBSTETRICS AND GYNECOLOGY | 4393 | 4% | 0% | 55 |
7 | CLINICAL OBSTETRICS AND GYNECOLOGY | 3461 | 1% | 1% | 21 |
8 | ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 2404 | 2% | 0% | 24 |
9 | JOURNAL OF REPRODUCTIVE MEDICINE | 2059 | 2% | 0% | 25 |
10 | BREAST CARE | 1780 | 0% | 1% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PREGNANCY ASSOCIATED BREAST CANCER | 243021 | 1% | 61% | 19 | Search PREGNANCY+ASSOCIATED+BREAST+CANCER | Search PREGNANCY+ASSOCIATED+BREAST+CANCER |
2 | PREGNANCY | 225334 | 45% | 2% | 657 | Search PREGNANCY | Search PREGNANCY |
3 | FETAL DOSE | 184218 | 1% | 55% | 16 | Search FETAL+DOSE | Search FETAL+DOSE |
4 | LACTATING ADENOMA | 104350 | 0% | 100% | 5 | Search LACTATING+ADENOMA | Search LACTATING+ADENOMA |
5 | PERIPHERAL DOSE | 90532 | 1% | 27% | 16 | Search PERIPHERAL+DOSE | Search PERIPHERAL+DOSE |
6 | PLACENTAL METASTASES | 83480 | 0% | 100% | 4 | Search PLACENTAL+METASTASES | Search PLACENTAL+METASTASES |
7 | GONADAL DOSE | 70290 | 1% | 42% | 8 | Search GONADAL+DOSE | Search GONADAL+DOSE |
8 | CHEMOTHERAPY IN PREGNANCY | 66783 | 0% | 80% | 4 | Search CHEMOTHERAPY+IN+PREGNANCY | Search CHEMOTHERAPY+IN+PREGNANCY |
9 | CERVICAL CANCER IN PREGNANCY | 62610 | 0% | 100% | 3 | Search CERVICAL+CANCER+IN+PREGNANCY | Search CERVICAL+CANCER+IN+PREGNANCY |
10 | LUNG CANCER IN PREGNANCY | 62610 | 0% | 100% | 3 | Search LUNG+CANCER+IN+PREGNANCY | Search LUNG+CANCER+IN+PREGNANCY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SELIG, BP , FURR, JR , HUEY, RW , MORAN, C , ALLURI, VN , MEDDERS, GR , MUMM, CD , HALLFORD, HG , MULVIHILL, JJ , (2012) CANCER CHEMOTHERAPEUTIC AGENTS AS HUMAN TERATOGENS.BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY. VOL. 94. ISSUE 8. P. 626 -650 | 176 | 77% | 8 |
2 | AZIM, HA , PAVLIDIS, N , PECCATORI, FA , (2010) TREATMENT OF THE PREGNANT MOTHER WITH CANCER: A SYSTEMATIC REVIEW ON THE USE OF CYTOTOXIC, ENDOCRINE, TARGETED AGENTS AND IMMUNOTHERAPY DURING PREGNANCY. PART II: HEMATOLOGICAL TUMORS.CANCER TREATMENT REVIEWS. VOL. 36. ISSUE 2. P. 110 -121 | 109 | 80% | 37 |
3 | MORICE, P , UZAN, C , GOUY, S , VERSCHRAEGEN, C , HAIE-MEDER, C , (2012) GYNAECOLOGICAL CANCERS IN PREGNANCY.LANCET. VOL. 379. ISSUE 9815. P. 558 -569 | 89 | 73% | 41 |
4 | AZIM, HA , PECCATORI, FA , PAVLIDIS, N , (2010) TREATMENT OF THE PREGNANT MOTHER WITH CANCER: A SYSTEMATIC REVIEW ON THE USE OF CYTOTOXIC, ENDOCRINE, TARGETED AGENTS AND IMMUNOTHERAPY DURING PREGNANCY. PART I: SOLID TUMORS.CANCER TREATMENT REVIEWS. VOL. 36. ISSUE 2. P. 101-109 | 85 | 81% | 28 |
5 | VOULGARIS, E , PENTHEROUDAKIS, G , PAVLIDIS, N , (2011) CANCER AND PREGNANCY: A COMPREHENSIVE REVIEW.SURGICAL ONCOLOGY-OXFORD. VOL. 20. ISSUE 4. P. E175 -E185 | 97 | 68% | 12 |
6 | THOMAS, X , (2015) ACUTE MYELOID LEUKEMIA IN THE PREGNANT PATIENT.EUROPEAN JOURNAL OF HAEMATOLOGY. VOL. 95. ISSUE 2. P. 124 -136 | 74 | 77% | 1 |
7 | RIZACK, T , MEGA, A , LEGARE, R , CASTILLO, J , (2009) MANAGEMENT OF HEMATOLOGICAL MALIGNANCIES DURING PREGNANCY.AMERICAN JOURNAL OF HEMATOLOGY. VOL. 84. ISSUE 12. P. 830-841 | 89 | 69% | 30 |
8 | AMANT, F , BREPOELS, L , HALASKA, MJ , GZIRI, MM , VAN CALSTEREN, K , (2010) GYNAECOLOGIC CANCER COMPLICATING PREGNANCY: AN OVERVIEW.BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY. VOL. 24. ISSUE 1. P. 61-79 | 85 | 66% | 27 |
9 | NGU, SF , NGAN, HYS , (2016) CHEMOTHERAPY IN PREGNANCY.BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY. VOL. 33. ISSUE . P. 86 -101 | 52 | 83% | 1 |
10 | DOTTERS-KATZ, S , MCNEIL, M , LIMMER, J , KULLER, J , (2014) CANCER AND PREGNANCY: THE CLINICIAN'S PERSPECTIVE.OBSTETRICAL & GYNECOLOGICAL SURVEY. VOL. 69. ISSUE 5. P. 277 -286 | 77 | 59% | 4 |
Classes with closest relation at Level 1 |